Effects of sphingosine 1-phosphate on calcium signaling, proliferation and S1P2 receptor expression in PCCl3 rat thyroid cells

被引:19
作者
Björklund, S
Palmberg, S
Rask, S
Westerdahl, AC
Törnquist, K
机构
[1] Abo Akad Univ, Dept Biol, Turku 20520, Finland
[2] Minerva Fdn, Inst Med Res, Helsinki, Finland
基金
芬兰科学院;
关键词
sphingolipids; proliferation; mitogen; receptors; intracellular calcium;
D O I
10.1016/j.mce.2004.12.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sphingosine 1-phosphate (S1P) regulates diverse biological processes, including mitosis, by binding to the SIP family of G-protein coupled receptors. The aim of the study was to determine the pattern of S1P receptor expression and to investigate the effects of S1P on intracellular calcium levels and proliferation in the rat thyroid cell line PC Cl-3. S1P(2) and S1P(3) mRNA and proteins were detected in PC 03 cells, as well as in FRTL-5 rat thyroid cells. In addition, S1P(5) mRNA was present at low levels, but not S1P, or S1P(4). In PC Cl-3 cells, S1P invoked calcium release from intracellular stores, but not calcium entry. The Ca2+ release was mediated by phospholipase C and inositol 1,4,5-trisphosphate. S1P attenuated the TSH-evoked cAMP increase in a pertussis toxin-sensitive manner. S1P per se did not affect the proliferation of the cells, but attenuated the proliferation evoked by a combination of insulin and TSH. Furthermore, S1P attenuated the PMA-evoked proliferation. S1P(2) expression was positively regulated by insulin and PMA. SIP itself transiently upregulated S1P(2) receptor mRNA, while TSH had a net downregulating effect on S1P(2) expression. In summary, S1P modulates central intracellular signaling cascades and is antiproliferative in PC Cl-3 cells. S1P(2) receptor expression is modulated by insulin and TSH, two central growth factors in thyroid cell regulation. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 39 条
  • [1] CULTURE OF HORMONE-DEPENDENT FUNCTIONAL EPITHELIAL-CELLS FROM RAT THYROIDS
    AMBESIIMPIOMBATO, FS
    PARKS, LAM
    COON, HG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3455 - 3459
  • [2] Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis
    Boguslawski, G
    Lyons, D
    Harvey, KA
    Kovala, AT
    English, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 603 - 609
  • [3] International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature
    Chun, J
    Goetzl, EJ
    Hla, T
    Igarashi, Y
    Lynch, KR
    Moolenaar, W
    Pyne, S
    Tigyi, G
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 265 - 269
  • [4] Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts - A cyclooxygenase-2 mediated pathway
    Davaille, J
    Gallois, C
    Habib, A
    Li, LY
    Mallat, A
    Tao, JC
    Levade, T
    Lotersztajn, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34628 - 34633
  • [5] GROWTH-FACTORS CONTROLLING THE THYROID-GLAND
    DUMONT, JE
    MAENHAUT, C
    PIRSON, I
    BAPTIST, M
    ROGER, PP
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1991, 5 (04): : 727 - 754
  • [6] Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells
    Ekokoski, E
    Webb, TE
    Simon, J
    Törnquist, K
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 187 (02) : 166 - 175
  • [7] ELIA MG, IN PRESS CELL SIGNAL
  • [8] Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity - Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene
    Florio, T
    Scorziello, A
    Fattore, M
    DAlto, V
    Salzano, S
    Rossi, G
    Berlingieri, MT
    Fusco, A
    Schettini, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6129 - 6136
  • [9] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [10] Human and rat alveolar macrophages express multiple EDG receptors
    Hornuss, C
    Hammermann, R
    Fuhrmann, M
    Juergens, UR
    Racké, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 429 (1-3) : 303 - 308